0 item $0.00

The Baker Institute is proud to partner with the Boehringer Ingelheim and Eli Lilly Australia & New Zealand Diabetes Alliance with the aim of bringing people together to focus on creating a healthier Australia.

Our shared values and desire is to make a difference to patients living with diabetes and heart disease. Our partnership and engagement aims to improve the knowledge of healthcare professionals, through a broad range of activities, such as the Dark shadow of type 2 diabetes report and GP Symposia, with impacts reaching nationally and globally.

Visit the Boehringer Ingelheim website

Visit the Eli Lilly Australia website

Support us

With the rising number of Australians affected by diabetes, heart disease and stroke, the need for research is more critical than ever.

Find out more